<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hematologic changes of pregnancy by trimester</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hematologic changes of pregnancy by trimester</h1>
<div class="graphic"><div class="figure"><div class="ttl">Hematologic changes of pregnancy by trimester</div><div class="cntnt"><table cellspacing="0"><colgroup width="25%"></colgroup><colgroup span="5" width="15%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Nonpregnant*</td> <td class="subtitle1">First trimester</td> <td class="subtitle1">Second trimester</td> <td class="subtitle1">Third trimester</td> <td class="subtitle1">References</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Hematology</td> </tr> <tr> <td class="indent1">Erythropoietin<sup>¶</sup> (units/L)</td> <td class="centered">4 to 27</td> <td class="centered">12 to 25</td> <td class="centered">8 to 67</td> <td class="centered">14 to 222</td> <td>1 to 3</td> </tr> <tr> <td class="indent1">Ferritin<sup>¶</sup> (ng/mL)</td> <td class="centered">10 to 150<sup>Δ</sup></td> <td class="centered">6 to 130</td> <td class="centered">2 to 230</td> <td class="centered">10 to 116</td> <td>1 to 8</td> </tr> <tr> <td class="indent1">Folate, red blood cell (ng/mL)</td> <td class="centered">150 to 450</td> <td class="centered">137 to 589</td> <td class="centered">94 to 828</td> <td class="centered">109 to 663</td> <td>6, 9, 10</td> </tr> <tr> <td class="indent1">Folate, serum (ng/mL)</td> <td class="centered">5.4 to 18.0</td> <td class="centered">2.6 to 15.0</td> <td class="centered">0.8 to 24.0</td> <td class="centered">1.4 to 20.7</td> <td>1, 6, 9 to 13</td> </tr> <tr> <td class="indent1">Haptoglobin (mg/mL)</td> <td class="centered">25 to 250</td> <td class="centered">130 +/- 43</td> <td class="centered">115 +/- 50</td> <td class="centered">135 +/- 65</td> <td>31</td> </tr> <tr> <td class="indent1">Hemoglobin<sup>¶</sup> (g/dL)</td> <td class="centered">12.0 to 15.8<sup>Δ</sup></td> <td class="centered">11.0 to 13.9</td> <td class="centered">10.6 to 14.8</td> <td class="centered">9.5 to 15.0</td> <td>2, 3, 6, 7, 13, 32</td> </tr> <tr> <td class="indent1">Hematocrit<sup>¶</sup> (%)</td> <td class="centered">35.4 to 44.4</td> <td class="centered">33.0 to 41.0</td> <td class="centered">32.0 to 39.0</td> <td class="centered">30.0 to 40.0</td> <td>1, 2, 5, 6, 13 to 15, 32</td> </tr> <tr> <td class="indent1">Iron, total binding capacity<sup>¶</sup> (mcg/dL)</td> <td class="centered">251 to 406</td> <td class="centered">278 to 403</td> <td class="centered">Not reported</td> <td class="centered">359 to 609</td> <td>7</td> </tr> <tr> <td class="indent1">Iron, serum<sup>¶</sup> (mcg/dL)</td> <td class="centered">41 to 141</td> <td class="centered">72 to 143</td> <td class="centered">44 to 178</td> <td class="centered">30 to 193</td> <td>2, 7</td> </tr> <tr> <td class="indent1">Mean corpuscular hemoglobin (pg/cell)</td> <td class="centered">27 to 32</td> <td class="centered">30 to 32</td> <td class="centered">30 to 33</td> <td class="centered">29 to 32</td> <td>5</td> </tr> <tr> <td class="indent1">Mean corpuscular volume (xm<sup>3</sup>)</td> <td class="centered">79 to 93</td> <td class="centered">81 to 96</td> <td class="centered">82 to 97</td> <td class="centered">81 to 99</td> <td>5, 6, 13, 14</td> </tr> <tr> <td class="indent1">Platelet (x10<sup>9</sup>/L)</td> <td class="centered">165 to 415</td> <td class="centered">174 to 391</td> <td class="centered">155 to 409</td> <td class="centered">146 to 429</td> <td>5, 6, 14, 16, 17</td> </tr> <tr> <td class="indent1">Mean platelet volume (mcm<sup>3</sup>)</td> <td class="centered">6.4 to 11.0</td> <td class="centered">7.7 to 10.3</td> <td class="centered">7.8 to 10.2</td> <td class="centered">8.2 to 10.4</td> <td>5</td> </tr> <tr> <td class="indent1">Red blood cell count (x10<sup>6</sup>/mm<sup>3</sup>)</td> <td class="centered">4.00 to 5.20<sup>Δ</sup></td> <td class="centered">3.42 to 4.55</td> <td class="centered">2.81 to 4.49</td> <td class="centered">2.71 to 4.43</td> <td>5, 6, 13, 14</td> </tr> <tr> <td class="indent1">Red cell distribution width (%)</td> <td class="centered">&lt;14.5</td> <td class="centered">12.5 to 14.1</td> <td class="centered">13.4 to 13.6</td> <td class="centered">12.7 to 15.3</td> <td>5</td> </tr> <tr> <td class="indent1">White blood cell count (x10<sup>3</sup>/mm<sup>3</sup>)</td> <td class="centered">3.5 to 9.1</td> <td class="centered">5.7 to 13.6</td> <td class="centered">5.6 to 14.8</td> <td class="centered">5.9 to 16.9</td> <td>5, 6, 13, 14, 18</td> </tr> <tr> <td class="indent2">Neutrophils (x10<sup>3</sup>/mm<sup>3</sup>)</td> <td class="centered">1.4 to 4.6</td> <td class="centered">3.6 to 10.1</td> <td class="centered">3.8 to 12.3</td> <td class="centered">3.9 to 13.1</td> <td>5, 14, 16, 18</td> </tr> <tr> <td class="indent2">Lymphocytes (x10<sup>3</sup>/mm<sup>3</sup>)</td> <td class="centered">0.7 to 4.6</td> <td class="centered">1.1 to 3.6</td> <td class="centered">0.9 to 3.9</td> <td class="centered">1.0 to 3.6</td> <td>5, 14, 16, 18</td> </tr> <tr> <td class="indent2">Monocytes (x10<sup>3</sup>/mm<sup>3</sup>)</td> <td class="centered">0.1 to 0.7</td> <td class="centered">0.1 to 1.1</td> <td class="centered">0.1 to 1.1</td> <td class="centered">0.1 to 1.4</td> <td>5, 14, 18</td> </tr> <tr> <td class="indent2">Eosinophils (x10<sup>3</sup>/mm<sup>3</sup>)</td> <td class="centered">0.0 to 0.6</td> <td class="centered">0.0 to 0.6</td> <td class="centered">0.0 to 0.6</td> <td class="centered">0.0 to 0.6</td> <td>14, 18</td> </tr> <tr> <td class="indent2">Basophils (x10<sup>3</sup>/mm<sup>3</sup>)</td> <td class="centered">0.0 to 0.2</td> <td class="centered">0.0 to 0.1</td> <td class="centered">0.0 to 0.1</td> <td class="centered">0.0 to 0.1</td> <td>14, 18</td> </tr> <tr> <td class="indent1">Transferrin (mg/dL)</td> <td class="centered">200 to 400</td> <td class="centered">254 to 344</td> <td class="centered">220 to 441</td> <td class="centered">288 to 530</td> <td>4, 5</td> </tr> <tr> <td class="indent1">Transferrin, saturation without iron (%)</td> <td class="centered">22 to 46<sup>¶</sup></td> <td class="centered">Not reported</td> <td class="centered">10 to 44</td> <td class="centered">5 to 37</td> <td>3</td> </tr> <tr class="divider_bottom"> <td class="indent1">Transferrin, saturation with iron (%)</td> <td class="centered">22 to 46<sup>¶</sup></td> <td class="centered">Not reported</td> <td class="centered">18 to 92</td> <td class="centered">9 to 98</td> <td>3</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Coagulation</td> </tr> <tr> <td class="indent1">Antithrombin, functional (%)</td> <td class="centered">70 to 130</td> <td class="centered">89 to 114</td> <td class="centered">78 to 126</td> <td class="centered">82 to 116</td> <td>17, 19, 20</td> </tr> <tr> <td class="indent1">D to dimer (mcg/mL)</td> <td class="centered">0.22 to 0.74</td> <td class="centered">0.05 to 0.95</td> <td class="centered">0.32 to 1.29</td> <td class="centered">0.13 to 1.70</td> <td>17, 20 to 24, 30</td> </tr> <tr> <td class="indent1">Factor V (%)</td> <td class="centered">50 to 150</td> <td class="centered">75 to 95</td> <td class="centered">72 to 96</td> <td class="centered">60 to 88</td> <td>25</td> </tr> <tr> <td class="indent1">Factor VII (%)</td> <td class="centered">50 to 150</td> <td class="centered">100 to 146</td> <td class="centered">95 to 153</td> <td class="centered">149 to 211</td> <td>17</td> </tr> <tr> <td class="indent1">Factor VIII (%)</td> <td class="centered">50 to 150</td> <td class="centered">90 to 210</td> <td class="centered">97 to 312</td> <td class="centered">143 to 353</td> <td>17, 25</td> </tr> <tr> <td class="indent1">Factor IX (%)</td> <td class="centered">50 to 150</td> <td class="centered">103 to 172</td> <td class="centered">154 to 217</td> <td class="centered">164 to 235</td> <td>17</td> </tr> <tr> <td class="indent1">Factor XI (%)</td> <td class="centered">50 to 150</td> <td class="centered">80 to 127</td> <td class="centered">82 to 144</td> <td class="centered">65 to 123</td> <td>17</td> </tr> <tr> <td class="indent1">Factor XII (%)</td> <td class="centered">50 to 150</td> <td class="centered">78 to 124</td> <td class="centered">90 to 151</td> <td class="centered">129 to 194</td> <td>17</td> </tr> <tr> <td class="indent1">Fibrinogen (mg/dL)</td> <td class="centered">211 to 496</td> <td class="centered">244 to 510</td> <td class="centered">291 to 538</td> <td class="centered">301 to 696</td> <td>5, 17, 20, 21, 23, 24, 30</td> </tr> <tr> <td class="indent1">Homocysteine (mmol/L)</td> <td class="centered">4.4 to 10.8</td> <td class="centered">3.34 to 11.00</td> <td class="centered">2.0 to 26.9</td> <td class="centered">3.2 to 21.4</td> <td>6, 9, 10 to 12</td> </tr> <tr> <td class="indent1">International normalized ratio</td> <td class="centered">0.90 to 1.04<sup>◊</sup></td> <td class="centered">0.86 to 1.08</td> <td class="centered">0.83 to 1.02</td> <td class="centered">0.80 to 1.09</td> <td>19, 24</td> </tr> <tr> <td class="indent1">Partial thromboplastin time, activated (seconds)</td> <td class="centered">26.3 to 39.4</td> <td class="centered">23.0 to 38.9</td> <td class="centered">22.9 to 38.1</td> <td class="centered">22.6 to 35.0</td> <td>5, 17, 19, 24</td> </tr> <tr> <td class="indent1">Plasminogen activator inhibitor to 1 (PAI to 1) antigen (pg/mL)</td> <td class="centered">17.3 ± 5.7</td> <td class="centered">17.7 ± 1.9</td> <td class="centered">Not reported</td> <td class="centered">66.4 ± 4.9</td> <td>30</td> </tr> <tr> <td class="indent1">Plasminogen activator inhibitor to 1 (PAI to 1) activity (arbitrary units)</td> <td class="centered">9.3 ± 1.9</td> <td class="centered">9.0 ± 0.8</td> <td class="centered">Not reported</td> <td class="centered">31.4 ± 3.0</td> <td>30</td> </tr> <tr> <td class="indent1">Prothrombin time (seconds)</td> <td class="centered">12.7 to 15.4</td> <td class="centered">9.7 to 13.5</td> <td class="centered">9.5 to 13.4</td> <td class="centered">9.6 to 12.9</td> <td>5, 17, 24</td> </tr> <tr> <td class="indent1">Protein C, functional (%)</td> <td class="centered">70 to 130</td> <td class="centered">78 to 121</td> <td class="centered">83 to 133</td> <td class="centered">67 to 135</td> <td>19, 25, 26</td> </tr> <tr> <td class="indent1">Protein S, total (%)</td> <td class="centered">70 to 140</td> <td class="centered">39 to 105</td> <td class="centered">27 to 101</td> <td class="centered">33 to 101</td> <td>17, 25, 26</td> </tr> <tr> <td class="indent1">Protein S, free (%)</td> <td class="centered">70 to 140</td> <td class="centered">34 to 133</td> <td class="centered">19 to 113</td> <td class="centered">20 to 65</td> <td>25, 26</td> </tr> <tr> <td class="indent1">Protein S, functional activity (%)</td> <td class="centered">65 to 140</td> <td class="centered">57 to 95</td> <td class="centered">42 to 68</td> <td class="centered">16 to 42</td> <td>25</td> </tr> <tr> <td class="indent1">Tissue plasminogen activator (ng/mL)</td> <td class="centered">1.6 to 13.0<sup>§</sup></td> <td class="centered">1.8 to 6.0</td> <td class="centered">2.36 to 6.60</td> <td class="centered">3.34 to 9.20</td> <td>17, 19, 30</td> </tr> <tr class="divider_bottom"> <td class="indent1">Tissue plasminogen activator inhibitor-1 (ng/mL)</td> <td class="centered">4 to 43</td> <td class="centered">16 to 33</td> <td class="centered">36 to 55</td> <td class="centered">67 to 92</td> <td>17</td> </tr> <tr> <td class="subtitle2_left" colspan="6">von Willebrand measurements</td> </tr> <tr> <td class="indent1">von Willebrand factor antigen (%)</td> <td class="centered">75 to 125</td> <td class="centered">62 to 318</td> <td class="centered">90 to 247</td> <td class="centered">84 to 422</td> <td>20, 27, 28</td> </tr> <tr> <td class="indent1">ADAMTS-13, von Willebrand cleaving protease</td> <td class="centered">40 to 170<sup>¥</sup></td> <td class="centered">40 to 160</td> <td class="centered">22 to 135</td> <td class="centered">38 to 105</td> <td>20, 28</td> </tr> </tbody></table></div><div class="graphic_footnotes">* Unless otherwise specified, all normal reference values are from the seventeenth edition of Harrison's Principles of Internal Medicine<sup>[29]</sup>.<br/>¶ Range includes references with and without iron supplementation.<br/>Δ Normal reference range is specific range for females.<br/><font class="lozenge">◊</font> Reference values are from Cerneca et al: Coagulation and fibrinolysis changes in normal pregnancy increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis<sup>[19]</sup>.<br/>§ References values are from Cerneca et al and Choi et al: Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy<sup>[17,19]</sup>.<br/>¥ Reference values are from Mannuci et al: Changes in health and disease of the metalloprotease that cleaves von Willebrand factor<sup>[28]</sup>.</div><div class="graphic_reference">References:<br/><ol>
<li>Beguin Y, Lipscei G, Thoumsin H, Fillet G. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood 1991; 78:89.</li>
<li>Bianco I, Mastropietro F, D'Asero C, et al. Serum levels of erythropoietin and soluble transferrin receptor during pregnancy in non-β-thalassemic and β-thalassemic women. Haematologica 2000; 85:902.</li>
<li>Milman N, Graudal N, Nielsen OJ, Agger AO. Serum erythropoietin during normal pregnancy: Relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women. Int J Hematol 1997; 66:159.</li>
<li>Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008; 115:874.</li>
<li>Lockitch G. Handbook of Diagnostic Biochemistry and Hematology in Normal Pregnancy. CRC Press, Boca Raton, FL, 1993.</li>
<li>Milman N, Bergholt T, Byg KE, et al. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Haematol 2007; 79:39.</li>
<li>Romslo I, Haram K, Sagen N, Augensen K. Iron requirement in normal pregnancy as assessed by serum ferritin, serum transferring saturation and erythrocyte protoporphyrin determinations. Br J Obstet Gynaecol 1983; 90:101.</li>
<li>van Buul EJ, Steegers EA, Jongsma HW, et al. Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med 1995; 46:73.</li>
<li>Milman N, Byg KE, Hvas AM, et al. Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: A longitudinal study comprising 404 Danish women. Eur J Haematol 2006; 76:200.</li>
<li>Walker MC, Smith GN, Perkins SL, et al. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999; 180:660.</li>
<li>López-Quesada E, Vilaseca MA, Lailla JM. Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 108:45.</li>
<li>Ozerol E, Ozerol I, Gökdeniz R, et al. Effect of smoking on serum concentrations of total homocysteine, folate, vitamin B12, and nitric oxide in pregnancy: A preliminary study. Fetal Diagn Ther 2004; 19:145.</li>
<li>Qvist I, Abdulla M, Jägerstad M, Svensson S. Iron, zinc and folate status during pregnancy and two months after delivery. Acta Obstet Gynecol Scand 1986; 65:15.</li>
<li>Balloch AJ, Cauchi MN. Reference ranges for haematology parameters in pregnancy derived from patient populations. Clin Lab Haematol 1993; 15:7.</li>
<li>Singh HJ, Mohammad NH, Nila A. Serum calcium and parathormone during normal pregnancy in Malay women. J Matern Fetal Med 1999; 8:95.</li>
<li>Karim SA, Khurshid M, Rizvi JH, et al. Platelets and leucocyte counts in pregnancy. J Pak Med Assoc 1992; 42:86.</li>
<li>Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol 2002; 81:611.</li>
<li>Belo L, Santos-Silva A, Rocha S, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123:46.</li>
<li>Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73:31.</li>
<li>Lattuada A, Rossi E, Calzarossa C, et al. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica 2003; 88:1029.</li>
<li>Francalanci I, Comeglio P, Liotta AA, et al. D-Dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 1995; 78:399.</li>
<li>Kline JA, Williams GW, Hernandez-Nino J. D-Dimer concentrations in normal pregnancy: New diagnostic thresholds are needed. Clin Chem 2005; 51:825.</li>
<li>Morse M. Establishing a normal range for D-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis. J Thromb Haemost 2004; 2:1202.</li>
<li>Liu XH, Jiang YM, Shi H, et al. Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women. Int J Gynaecol Obstet 2009; 105:240.</li>
<li>Lefkowitz JB, Clarke SH, Barbour LA. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996; 175:657.</li>
<li>Faught W, Garner P, Jones G, Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995; 172:147.</li>
<li>Wickström K, Edelstam G, Löwbeer CH, et al. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004; 64:31.</li>
<li>Mannucci PM, Canciani MT, Forza I, et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98:2730.</li>
<li>Kratz A, Pesce MA, Basner RC, Einstein AJ. Appendix: Laboratory values of clinical importance. In: Harrison's Principles of Internal Medicine, 18th ed, Longo DL, Fauci AS, Kasper DL, et al (Eds), McGraw-Hill, New York 2012.</li>
<li>Hale SA, Sobel B, Benvenuto A, et al. Coagulation and fibrinolytic system protein profiles in women with normal pregnancies and pregnancies complicated by hypertension. Pregnancy Hypertens 2012; 2:152.</li>
<li>Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983; 90:139.</li>
<li>Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency anemia in the United States. MMWR Recomm Rep 1998; 47:1.</li></ol></div><div id="graphicVersion">Graphic 115338 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
